Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04537715
Title A Two-part Study to Characterize Drug-Drug Interaction Effects on Steady-State Pharmacokinetics of Oral Tazemetostat
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Epizyme, Inc.
Indications

hematologic cancer

Advanced Solid Tumor

Therapies

Itraconazole + Tazemetostat

Rifampin + Tazemetostat

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST